Entry |
|
Symbol |
AKT3
|
Name |
(RefSeq) RAC-gamma serine/threonine-protein kinase isoform X1
|
KO |
|
Organism |
aml Ailuropoda melanoleuca (giant panda)
|
Pathway |
aml01521 | EGFR tyrosine kinase inhibitor resistance |
aml04072 | Phospholipase D signaling pathway |
aml04213 | Longevity regulating pathway - multiple species |
aml04261 | Adrenergic signaling in cardiomyocytes |
aml04550 | Signaling pathways regulating pluripotency of stem cells |
aml04613 | Neutrophil extracellular trap formation |
aml04620 | Toll-like receptor signaling pathway |
aml04625 | C-type lectin receptor signaling pathway |
aml04660 | T cell receptor signaling pathway |
aml04662 | B cell receptor signaling pathway |
aml04664 | Fc epsilon RI signaling pathway |
aml04666 | Fc gamma R-mediated phagocytosis |
aml04810 | Regulation of actin cytoskeleton |
aml04914 | Progesterone-mediated oocyte maturation |
aml04919 | Thyroid hormone signaling pathway |
aml04920 | Adipocytokine signaling pathway |
aml04923 | Regulation of lipolysis in adipocytes |
aml04932 | Non-alcoholic fatty liver disease |
aml04933 | AGE-RAGE signaling pathway in diabetic complications |
aml04935 | Growth hormone synthesis, secretion and action |
aml04973 | Carbohydrate digestion and absorption |
aml05163 | Human cytomegalovirus infection |
aml05166 | Human T-cell leukemia virus 1 infection |
aml05167 | Kaposi sarcoma-associated herpesvirus infection |
aml05168 | Herpes simplex virus 1 infection |
aml05170 | Human immunodeficiency virus 1 infection |
aml05207 | Chemical carcinogenesis - receptor activation |
aml05208 | Chemical carcinogenesis - reactive oxygen species |
aml05230 | Central carbon metabolism in cancer |
aml05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
aml05418 | Fluid shear stress and atherosclerosis |
|
Brite |
KEGG Orthology (KO) [BR:aml00001]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
100480414 (AKT3)
04012 ErbB signaling pathway
100480414 (AKT3)
04014 Ras signaling pathway
100480414 (AKT3)
04015 Rap1 signaling pathway
100480414 (AKT3)
04370 VEGF signaling pathway
100480414 (AKT3)
04371 Apelin signaling pathway
100480414 (AKT3)
04630 JAK-STAT signaling pathway
100480414 (AKT3)
04668 TNF signaling pathway
100480414 (AKT3)
04066 HIF-1 signaling pathway
100480414 (AKT3)
04068 FoxO signaling pathway
100480414 (AKT3)
04072 Phospholipase D signaling pathway
100480414 (AKT3)
04071 Sphingolipid signaling pathway
100480414 (AKT3)
04024 cAMP signaling pathway
100480414 (AKT3)
04022 cGMP-PKG signaling pathway
100480414 (AKT3)
04151 PI3K-Akt signaling pathway
100480414 (AKT3)
04152 AMPK signaling pathway
100480414 (AKT3)
04150 mTOR signaling pathway
100480414 (AKT3)
09140 Cellular Processes
09141 Transport and catabolism
04140 Autophagy - animal
100480414 (AKT3)
09143 Cell growth and death
04210 Apoptosis
100480414 (AKT3)
04218 Cellular senescence
100480414 (AKT3)
09144 Cellular community - eukaryotes
04510 Focal adhesion
100480414 (AKT3)
04550 Signaling pathways regulating pluripotency of stem cells
100480414 (AKT3)
09142 Cell motility
04810 Regulation of actin cytoskeleton
100480414 (AKT3)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
100480414 (AKT3)
04613 Neutrophil extracellular trap formation
100480414 (AKT3)
04620 Toll-like receptor signaling pathway
100480414 (AKT3)
04625 C-type lectin receptor signaling pathway
100480414 (AKT3)
04660 T cell receptor signaling pathway
100480414 (AKT3)
04662 B cell receptor signaling pathway
100480414 (AKT3)
04664 Fc epsilon RI signaling pathway
100480414 (AKT3)
04666 Fc gamma R-mediated phagocytosis
100480414 (AKT3)
04062 Chemokine signaling pathway
100480414 (AKT3)
09152 Endocrine system
04910 Insulin signaling pathway
100480414 (AKT3)
04922 Glucagon signaling pathway
100480414 (AKT3)
04923 Regulation of lipolysis in adipocytes
100480414 (AKT3)
04920 Adipocytokine signaling pathway
100480414 (AKT3)
04929 GnRH secretion
100480414 (AKT3)
04915 Estrogen signaling pathway
100480414 (AKT3)
04914 Progesterone-mediated oocyte maturation
100480414 (AKT3)
04917 Prolactin signaling pathway
100480414 (AKT3)
04926 Relaxin signaling pathway
100480414 (AKT3)
04935 Growth hormone synthesis, secretion and action
100480414 (AKT3)
04919 Thyroid hormone signaling pathway
100480414 (AKT3)
09153 Circulatory system
04261 Adrenergic signaling in cardiomyocytes
100480414 (AKT3)
09154 Digestive system
04973 Carbohydrate digestion and absorption
100480414 (AKT3)
09156 Nervous system
04725 Cholinergic synapse
100480414 (AKT3)
04728 Dopaminergic synapse
100480414 (AKT3)
04722 Neurotrophin signaling pathway
100480414 (AKT3)
09158 Development and regeneration
04380 Osteoclast differentiation
100480414 (AKT3)
09149 Aging
04211 Longevity regulating pathway
100480414 (AKT3)
04213 Longevity regulating pathway - multiple species
100480414 (AKT3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
100480414 (AKT3)
05205 Proteoglycans in cancer
100480414 (AKT3)
05207 Chemical carcinogenesis - receptor activation
100480414 (AKT3)
05208 Chemical carcinogenesis - reactive oxygen species
100480414 (AKT3)
05230 Central carbon metabolism in cancer
100480414 (AKT3)
05231 Choline metabolism in cancer
100480414 (AKT3)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
100480414 (AKT3)
09162 Cancer: specific types
05210 Colorectal cancer
100480414 (AKT3)
05212 Pancreatic cancer
100480414 (AKT3)
05225 Hepatocellular carcinoma
100480414 (AKT3)
05226 Gastric cancer
100480414 (AKT3)
05214 Glioma
100480414 (AKT3)
05221 Acute myeloid leukemia
100480414 (AKT3)
05220 Chronic myeloid leukemia
100480414 (AKT3)
05218 Melanoma
100480414 (AKT3)
05211 Renal cell carcinoma
100480414 (AKT3)
05215 Prostate cancer
100480414 (AKT3)
05213 Endometrial cancer
100480414 (AKT3)
05224 Breast cancer
100480414 (AKT3)
05222 Small cell lung cancer
100480414 (AKT3)
05223 Non-small cell lung cancer
100480414 (AKT3)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
100480414 (AKT3)
05170 Human immunodeficiency virus 1 infection
100480414 (AKT3)
05161 Hepatitis B
100480414 (AKT3)
05160 Hepatitis C
100480414 (AKT3)
05164 Influenza A
100480414 (AKT3)
05162 Measles
100480414 (AKT3)
05168 Herpes simplex virus 1 infection
100480414 (AKT3)
05163 Human cytomegalovirus infection
100480414 (AKT3)
05167 Kaposi sarcoma-associated herpesvirus infection
100480414 (AKT3)
05169 Epstein-Barr virus infection
100480414 (AKT3)
05165 Human papillomavirus infection
100480414 (AKT3)
09171 Infectious disease: bacterial
05132 Salmonella infection
100480414 (AKT3)
05135 Yersinia infection
100480414 (AKT3)
05152 Tuberculosis
100480414 (AKT3)
09174 Infectious disease: parasitic
05145 Toxoplasmosis
100480414 (AKT3)
05142 Chagas disease
100480414 (AKT3)
09164 Neurodegenerative disease
05010 Alzheimer disease
100480414 (AKT3)
05017 Spinocerebellar ataxia
100480414 (AKT3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
100480414 (AKT3)
05418 Fluid shear stress and atherosclerosis
100480414 (AKT3)
05415 Diabetic cardiomyopathy
100480414 (AKT3)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
100480414 (AKT3)
04932 Non-alcoholic fatty liver disease
100480414 (AKT3)
04931 Insulin resistance
100480414 (AKT3)
04933 AGE-RAGE signaling pathway in diabetic complications
100480414 (AKT3)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
100480414 (AKT3)
01524 Platinum drug resistance
100480414 (AKT3)
01522 Endocrine resistance
100480414 (AKT3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:aml01001]
100480414 (AKT3)
Enzymes [BR:aml01000]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.11 Protein-serine/threonine kinases
2.7.11.1 non-specific serine/threonine protein kinase
100480414 (AKT3)
Protein kinases [BR:aml01001]
Serine/threonine kinases: AGC group
AKT/PKB family
100480414 (AKT3)
|
SSDB |
|
Motif |
|
Other DBs |
|
LinkDB |
|
Position |
8:68379969..68678624
|
AA seq |
479 aa
MSDVTVVKEGWVQKRGEYIKNWRPRYFLLKTDGSFIGYKEKPQDVDLPYPLNNFSVAKCQ
LMKTERPKPNTFIIRCLQWTTVIERTFHVDTPEEREEWTEAIQAVADRLQRQEEERMNCS
PTSQIDNIGEEEMDASTTHHKRKTMNDFDYLKLLGKGTFGKVILVREKASGKYYAMKILK
KEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRE
RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA
ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM
EDIKFPRTLSSDAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFSGVNWQDVYDKKLVP
PFKPQVTSETDTRYFDEEFTAQTITITPPEKYDEDGMDCVDNERRPHFPQFSYSASGRE |
NT seq |
1440 nt +upstreamnt +downstreamnt
atgagcgatgttaccgtcgtgaaagaaggctgggttcagaagaggggagaatatataaaa
aactggaggccaagatatttccttttgaagacagatggctcattcataggatataaagag
aaacctcaagatgtggatttaccttatcccctcaacaacttttcagtggcaaaatgccag
ttaatgaaaacagaacgaccaaagccaaacacatttattatcagatgtctccagtggacc
actgttatagagagaacgtttcatgtagatacaccagaggaaagggaagagtggacagaa
gctattcaggctgtagcagacagacttcagagacaagaagaggagagaatgaattgtagt
ccaacttcacaaattgataatataggggaagaagagatggatgcttccacaacccatcat
aaaagaaagacaatgaatgattttgactatttgaaactgctaggtaaaggcacttttggg
aaagttattttggttcgagagaaggcaagtgggaaatactatgctatgaagattctgaag
aaagaagttattattgcaaaggatgaagtggcacatactctaactgaaagcagagtatta
aagaacactagacatccctttttaacatccttgaaatattccttccagacaaaagaccgt
ttgtgttttgtgatggaatatgtaaatgggggagagctgtttttccatttgtcgagagag
cgggtgttctccgaggaccgcacacgtttctatggtgcagaaattgtctctgctttggac
tatctacattccggaaagattgtgtaccgtgatctcaagttggagaatttgatgctggat
aaagatggccacataaaaatcacggactttgggctttgcaaagaagggatcacggacgcg
gccaccatgaagacgttctgtggcacaccggagtacctggcacccgaggtattagaagac
aacgactatggccgagccgtggattggtggggcctgggggtcgtcatgtatgagatgatg
tgtgggaggctacctttctacaaccaggatcatgagaaactttttgaactaatactaatg
gaagacattaaatttcctcgaacactctcttcagatgcaaaatcactgctttcagggctc
ttgataaaggatccaaataagcgccttggcgggggcccagatgatgcaaaagaaattatg
aggcacagtttcttctctggagtcaactggcaagatgtatacgataaaaagcttgtacct
ccttttaagcctcaagtaacatctgagacagataccaggtattttgatgaagaatttaca
gctcagactattacaataacgccacctgaaaaatatgacgaggacggcatggactgcgtg
gacaacgagcggcggccgcacttccctcagttctcctactccgccagtggccgcgagtaa |